What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Gene
His primary areas of investigation include Internal medicine, Immunology, Scleroderma, Rheumatology and Connective tissue disease.
His research integrates issues of Gastroenterology, Endocrinology and Surgery in his study of Internal medicine.
His Immunology study integrates concerns from other disciplines, such as Receptor, Vascular endothelial growth factor and Oncology.
His research in Rheumatology intersects with topics in Framingham Heart Study, Hyperuricemia, Observer variation and Disease.
His biological study spans a wide range of topics, including Systemic disease, Fibrosis and CTGF.
He combines subjects such as Acr criteria and Skin thickening with his study of Interstitial lung disease.
His most cited work include:
- 2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative (1669 citations)
- Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database (658 citations)
- 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative (583 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Rheumatoid arthritis, Immunology, Rheumatology and Pathology.
Ulf Müller-Ladner has researched Internal medicine in several fields, including Endocrinology, Surgery and Physical therapy.
His studies deal with areas such as Rheumatism and Evidence-based medicine, MEDLINE as well as Physical therapy.
The concepts of his Rheumatoid arthritis study are interwoven with issues in Adverse effect, Pharmacology and Methotrexate.
His Rheumatology research integrates issues from Medical laboratory, Disease and Intensive care medicine.
His Pathology research is multidisciplinary, incorporating elements of Cartilage and Synovial membrane.
He most often published in these fields:
- Internal medicine (41.78%)
- Rheumatoid arthritis (20.72%)
- Immunology (16.12%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (41.78%)
- Rheumatoid arthritis (20.72%)
- Rheumatology (15.62%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Rheumatoid arthritis, Rheumatology, Adipokine and Endocrinology.
His research brings together the fields of Gastroenterology and Internal medicine.
His Rheumatoid arthritis study necessitates a more in-depth grasp of Immunology.
Ulf Müller-Ladner has included themes like MEDLINE, Dermatology, Intensive care medicine, Medical laboratory and Disease in his Rheumatology study.
His Adipokine research includes elements of Adipose tissue and Adiponectin.
His work in Endocrinology addresses issues such as Proinflammatory cytokine, which are connected to fields such as Cytokine.
Between 2017 and 2021, his most popular works were:
- 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases (144 citations)
- Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate) (130 citations)
- Impfen bei Immundefizienz : Anwendungshinweise zu den von der Ständigen Impfkommission empfohlenen Impfungen. (IV) Impfen bei Autoimmunkrankheiten, bei anderen chronisch-entzündlichen Erkrankungen und unter immunmodulatorischer Therapie. (54 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Gene
His scientific interests lie mostly in Internal medicine, Rheumatology, Scleroderma, Rheumatoid arthritis and Cohort.
Within one scientific family, Ulf Müller-Ladner focuses on topics pertaining to Endocrinology under Internal medicine, and may sometimes address concerns connected to Inflammation.
Ulf Müller-Ladner interconnects Nailfold Capillaroscopy, Intensive care medicine, Bosentan, Iloprost and Pathology in the investigation of issues within Rheumatology.
His study in Scleroderma is interdisciplinary in nature, drawing from both Disease progression and Rheumatism.
The various areas that Ulf Müller-Ladner examines in his Rheumatoid arthritis study include Peripheral, Dermatology, Rate ratio, Rituximab and Prevalence.
His Cohort research includes themes of Gangrene, Pulmonary hypertension, Systemic scleroderma, Disease and Proteinuria.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
